STRATEC Biomedical AG (SBS) NPV
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
- Add to watchlist
- This stock can be held in a
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
Annual & interim reports
Annual & interim reports are not available for this stock.
Financial results for the last 5 years
Values are quoted in the stock's local currency: Euro.
Income Statement: | 31/12/2018 | 31/12/2017 | 31/12/2016 | 31/12/2015 | 31/12/2014 |
---|---|---|---|---|---|
€ (Millions) | € (Millions) | € (Millions) | € (Millions) | € (Millions) | |
Revenue: | 187.82 | 209.76 | 184.91 | 146.89 | 144.86 |
Operating Profit / (Loss): | 15.01 | 28.84 | 24.13 | 26.88 | 24.05 |
Net Interest: | n/a | n/a | n/a | n/a | n/a |
Profit Before Tax: | 14.09 | 28.03 | 22.85 | 27.17 | 24.05 |
Profit after tax from continuing operations: | 11.11 | 25.63 | 19.50 | 22.08 | 19.77 |
Discontinued Operations: | |||||
Profit after tax from discontinuing operations: | n/a | n/a | n/a | n/a | n/a |
Profit for the period: | n/a | n/a | n/a | n/a | n/a |
Attributable to: | |||||
Equity holders of parent company: | n/a | n/a | n/a | n/a | n/a |
Minority Interests / Other Equity: | n/a | n/a | n/a | n/a | n/a |
Total Dividend Paid: | c n/a | c n/a | c n/a | c n/a | c n/a |
Retained Profit / (Loss) for the Financial Year: | c n/a | c n/a | c n/a | c n/a | c n/a |
Earnings per Share: | |||||
Basic: | 75.00¢ | 216.00¢ | 165.00¢ | 187.00¢ | 168.00¢ |
Diluted: | n/a | n/a | n/a | n/a | n/a |
Adjusted: | 75.00¢ | 216.00¢ | 165.00¢ | 187.00¢ | 168.00¢ |
Dividend per Share: | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
Balance Sheet: | 31/12/2018 | 31/12/2017 | 31/12/2016 | 31/12/2015 | 31/12/2014 |
Assets: | |||||
Non-Current Assets: | |||||
Property, Plant & Equipment: | n/a | n/a | n/a | n/a | n/a |
Intangible Assets: | n/a | n/a | n/a | n/a | n/a |
Investment Properties: | n/a | n/a | n/a | n/a | n/a |
Investments: | n/a | n/a | n/a | n/a | n/a |
Other Financial Assets: | n/a | n/a | n/a | n/a | n/a |
Other Non-Current Assets: | n/a | n/a | n/a | n/a | n/a |
n/a | n/a | n/a | n/a | n/a | |
Current Assets: | |||||
Inventories: | n/a | n/a | n/a | n/a | n/a |
Trade and Other Receivables: | n/a | n/a | n/a | n/a | n/a |
Cash at Bank & In Hand: | n/a | n/a | n/a | n/a | n/a |
Current Asset Investments: | n/a | n/a | n/a | n/a | n/a |
Other Current Assets: | n/a | n/a | n/a | n/a | n/a |
n/a | n/a | n/a | n/a | n/a | |
Other Assets: | n/a | n/a | n/a | n/a | n/a |
Total Assets: | n/a | n/a | n/a | n/a | n/a |
Liabilities: | |||||
Current Liabilities: | |||||
Borrowings: | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities: | n/a | n/a | n/a | n/a | n/a |
n/a | n/a | n/a | n/a | n/a | |
Net Current Assets: | c n/a | c n/a | c n/a | c n/a | c n/a |
Non-Current Liabilities: | |||||
Borrowings: | n/a | n/a | n/a | n/a | n/a |
Provisions: | n/a | n/a | n/a | n/a | n/a |
Other Non-Current Liabilities: | n/a | n/a | n/a | n/a | n/a |
n/a | n/a | n/a | n/a | n/a | |
Other Liabilities: | n/a | n/a | n/a | n/a | n/a |
Total Liabilities: | n/a | n/a | n/a | n/a | n/a |
Net Assets: | n/a | n/a | n/a | n/a | n/a |
Capital & reserves: | |||||
Share Capital: | n/a | n/a | n/a | n/a | n/a |
Share Premium Account: | n/a | n/a | n/a | n/a | n/a |
Other Reserves: | n/a | n/a | n/a | n/a | n/a |
Retained Earnings: | n/a | n/a | n/a | n/a | n/a |
Shareholders Funds: | n/a | n/a | n/a | n/a | n/a |
Minority Interests / Other Equity: | n/a | n/a | n/a | n/a | n/a |
Total Equity: | n/a | n/a | n/a | n/a | n/a |
a. Includes discontinued activities
b. Including assets due in more than one year
c. Not disclosed under IFRS
d. Total fixed assets
e. Includes borrowings
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.